Gabriel G Haddad Selected Research

LDL Receptors (LDL Receptor)

12/2019	Intermittent hypoxia and hypercapnia induces inhibitor of nuclear factor-κB kinase subunit β-dependent atherosclerosis in pulmonary arteries.
12/2013	Intermittent hypoxia and hypercapnia induce pulmonary artery atherosclerosis and ventricular dysfunction in low density lipoprotein receptor deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriel G Haddad Research Topics

Disease

51	Hypoxia (Hypoxemia) 01/2023 - 02/2002
9	Hypercapnia 06/2021 - 12/2006
6	Hyperoxia 12/2014 - 07/2010
5	Atherosclerosis 01/2021 - 12/2013
5	Ischemia 12/2016 - 09/2004
4	Acidosis 01/2018 - 03/2007
4	Stroke (Strokes) 01/2012 - 12/2003
3	Cardiomegaly (Heart Hypertrophy) 10/2018 - 08/2005
2	Opioid-Related Disorders (Opiate Addiction) 11/2023 - 01/2023
2	Neoplasms (Cancer) 01/2021 - 04/2014
2	Cardiomyopathies (Cardiomyopathy) 10/2018 - 08/2010
2	Brain Injuries (Brain Injury) 12/2016 - 02/2013
2	Pulmonary Hypertension 09/2015 - 03/2012
2	Glioma (Gliomas) 04/2014 - 01/2014
2	Infarction (Infarctions) 01/2012 - 03/2007
2	Brain Ischemia (Cerebral Ischemia) 01/2010 - 12/2003
2	Vascular Diseases (Vascular Disease) 01/2009 - 01/2009
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2009 - 01/2009
2	Lung Injury 01/2009 - 01/2009
2	Lung Diseases (Lung Disease) 01/2009 - 01/2009
2	Dehydration (Water Stress) 08/2004 - 02/2002
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2023
1	Substance-Related Disorders (Drug Abuse) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Schizophrenia (Dementia Praecox) 01/2022
1	Amyloid Plaque 01/2022
1	Autistic Disorder (Autism) 01/2022
1	Hematologic Diseases (Blood Diseases) 01/2021
1	Myocardial Infarction 01/2021
1	Ischemic Stroke 01/2021
1	Polycythemia (Erythrocytosis) 01/2021
1	Neonatal Abstinence Syndrome 12/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Airway Obstruction (Choking) 12/2019
1	Obstructive Sleep Apnea 03/2019
1	Hypertrophy 10/2018
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 10/2018

Drug/Important Bio-Agent (IBA)

13	Oxygen (Dioxygen)IBA 01/2018 - 05/2003
9	Proteins (Proteins, Gene)FDA Link 05/2012 - 02/2002
6	ElementsIBA 01/2021 - 05/2007
6	Adenosine Triphosphate (ATP)IBA 01/2018 - 02/2008
5	Protein Isoforms (Isoforms)IBA 10/2018 - 12/2003
5	AcidsIBA 01/2018 - 09/2007
5	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2014 - 07/2011
4	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 04/2014 - 06/2007
4	Glucose (Dextrose)FDA LinkGeneric 01/2012 - 06/2003
4	Oxidants (Oxidizing Agents)IBA 07/2011 - 02/2002
3	Methadone (Dolophine)FDA LinkGeneric 11/2023 - 01/2020
3	Phosphotransferases (Kinase)IBA 01/2023 - 06/2008
3	Ion Channels (Ion Channel)IBA 01/2020 - 01/2008
3	ParaquatIBA 12/2014 - 07/2011
3	Phosphates (Orthophosphate)IBA 08/2004 - 02/2002
3	TrehaloseIBA 08/2004 - 02/2002
2	Opioid Analgesics (Opioids)IBA 01/2023 - 12/2020
2	ChromatinIBA 01/2022 - 01/2012
2	Phenobarbital (Luminal)FDA Link 06/2021 - 01/2021
2	LDL Receptors (LDL Receptor)IBA 12/2019 - 12/2013
2	Apolipoproteins E (ApoE)IBA 03/2019 - 11/2017
2	RNA (Ribonucleic Acid)IBA 10/2018 - 08/2005
2	Messenger RNA (mRNA)IBA 10/2018 - 01/2012
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2018 - 08/2015
2	Endothelin Receptors (Endothelin Receptor)IBA 01/2018 - 08/2015
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018 - 02/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 08/2008
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 09/2015 - 02/2011
2	Triglycerides (Triacylglycerol)IBA 12/2013 - 01/2012
2	Superoxides (Superoxide)IBA 05/2012 - 01/2012
2	Coloring Agents (Dyes)IBA 05/2012 - 01/2008
2	acetovanillone (apocynin)IBA 05/2012 - 03/2012
2	NADPH Oxidases (NAD(P)H oxidase)IBA 05/2012 - 03/2012
2	IonsIBA 01/2012 - 09/2004
2	AntioxidantsIBA 02/2011 - 12/2006
2	EnzymesIBA 02/2011 - 06/2003
2	Sodium-Hydrogen ExchangersIBA 08/2010 - 02/2008
2	SolutionsIBA 02/2009 - 03/2007
2	4,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA 02/2009 - 02/2008
1	Buprenorphine (Subutex)FDA LinkGeneric 11/2023
1	Casein Kinase II (Casein Kinase 2)IBA 01/2023
1	AntibodiesIBA 01/2022
1	Transcription Factor 4IBA 01/2022
1	TropomodulinIBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Excitatory Amino AcidsIBA 01/2021
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2021
1	MAP Kinase Kinase 4IBA 01/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	16S Ribosomal RNAIBA 03/2019
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2018
1	MicroRNAs (MicroRNA)IBA 10/2018
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 10/2018
1	Bosentan (Tracleer)FDA Link 01/2018
1	BQ 788IBA 01/2018

Therapy/Procedure

3	Therapeutics 09/2015 - 12/2003
2	Precision Medicine 01/2009 - 01/2009
1	Artificial Respiration (Mechanical Ventilation) 01/2023